The overexpression of TPX2 has been reported in various malignancies such as pancreatic cancer 4, colon cancer 5, esophageal squamous cell carcinoma 6, bladder carcinoma 7, and hepatocellular carcinoma 8. This evidence concerns the gene TPX2 and familial pancreatic carcinoma.